APA (7th ed.) Citation

Zambrotta, G. P. M., Nicolini, F. E., Assouline, S., Busque, L., Pungolino, E., Abruzzese, E., . . . Gambacorti-Passerini, C. (2023). Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study. American journal of hematology, 98(11), . https://doi.org/10.1002/ajh.27073

Chicago Style (17th ed.) Citation

Zambrotta, Giovanni Paolo Maria, et al. "Risk of Progression in Chronic Phase-chronic Myeloid Leukemia Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation: Final Analysis of the TFR-PRO Study." American Journal of Hematology 98, no. 11 (2023). https://doi.org/10.1002/ajh.27073.

MLA (9th ed.) Citation

Zambrotta, Giovanni Paolo Maria, et al. "Risk of Progression in Chronic Phase-chronic Myeloid Leukemia Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation: Final Analysis of the TFR-PRO Study." American Journal of Hematology, vol. 98, no. 11, 2023, https://doi.org/10.1002/ajh.27073.